<article>
    <h2>HHS Winds Down mRNA Vaccine Development Under BARDA</h2>
    <div>
 <div>
 

  <h2>Summary</h2>
 

  <p>The U.S. Department of Health and Human Services (HHS) announced the conclusion of its mRNA vaccine development program under the Biomedical Advanced Research and Development Authority (BARDA). This program, initiated to advance mRNA technology for a range of infectious diseases, has achieved its objectives. According to the announcement, the initial goals of creating a platform and the technology transfer to the private sector have been successfully completed. Therefore, HHS will be winding down the program.</p>
 

  <h2>Key Points</h2>
 

  <ul>
  <li>HHS is ending its mRNA vaccine development program under BARDA.</li>
  <li>The program's goals of platform creation and technology transfer to the private sector have been met.</li>
  </ul>
 </div>
 </div>
</article>
